Works by van Laarhoven, H. W. M.


Results: 42
    1

    Decision Making about Localized Esophageal Cancer Treatment: An Observational Study on Variation in Clinicians' Communication Behavior.

    Published in:
    MDM Policy & Practice, 2025, v. 10, n. 1, p. 1, doi. 10.1177/23814683251349473
    By:
    • van de Water, L. F.;
    • Scholten, G. C.;
    • Henselmans, I.;
    • Heisterkamp, J.;
    • Jeene, P. M.;
    • Heesakkers, F. F. B. M.;
    • Neelis, K. J.;
    • Klarenbeek, B. R.;
    • van Berge Henegouwen, M. I.;
    • van den Berg, J. W.;
    • Buijsen, J.;
    • Geijsen, E. D.;
    • van Laarhoven, H. W. M.;
    • Smets, E. M. A.
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Correction: Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design.

    Published in:
    2023
    By:
    • Doppenberg, D.;
    • Besselink, M. G.;
    • van Eijck, C. H. J.;
    • Intven, M. P. W.;
    • Groot Koerkamp, B.;
    • Kazemier, G.;
    • van Laarhoven, H. W. M.;
    • Meijerink, M.;
    • Molenaar, I. Q.;
    • Nuyttens, J. J. M. E.;
    • van Os, R.;
    • van Santvoort, H. C.;
    • van Tienhoven, G.;
    • Verkooijen, H. M.;
    • Versteijne, E.;
    • Wilmink, J. W.;
    • Lagerwaard, F. J.;
    • Bruynzeel, A. M. E.
    Publication type:
    Correction Notice
    14

    Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design.

    Published in:
    BMC Cancer, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12885-022-10419-4
    By:
    • Doppenberg, D.;
    • Besselink, M. G.;
    • van Eijck, C. H. J.;
    • Intven, M. P. W.;
    • Koerkamp, B. Groot;
    • Kazemier, G.;
    • van Laarhoven, H. W. M.;
    • Meijerink, M.;
    • Molenaar, I. Q.;
    • Nuyttens, J. J. M. E.;
    • van Os, R.;
    • van Santvoort, H. C.;
    • van Tienhoven, G.;
    • Verkooijen, H. M.;
    • Versteijne, E.;
    • Wilmink, J. W.;
    • Lagerwaard, F. J.;
    • Bruynzeel, A. M. E.
    Publication type:
    Article
    15
    16

    Pre-treatment tumor-infiltrating T cells influence response to neoadjuvant chemoradiotherapy in esophageal adenocarcinoma.

    Published in:
    OncoImmunology, 2021, v. 10, n. 1, p. 1, doi. 10.1080/2162402X.2021.1954807
    By:
    • Goedegebuure, R. S. A.;
    • Harrasser, M.;
    • de Klerk, L. K.;
    • van Schooten, T. S.;
    • van Grieken, N. C. T.;
    • Eken, M.;
    • Grifhorst, M. S.;
    • Pocorni, N.;
    • Jordanova, E. S.;
    • van Berge Henegouwen, M. I.;
    • Pouw, R. E.;
    • Verheul, H. M. W.;
    • van der Vliet, J. J.;
    • van Laarhoven, H. W. M.;
    • Thijssen, V. L. J. L.;
    • Bass, A. J.;
    • De Gruijl, T. D.;
    • Derks, S.
    Publication type:
    Article
    17
    18
    19

    Treatment strategies in recurrent esophageal or junctional cancer.

    Published in:
    Diseases of the Esophagus, 2017, v. 30, n. 9, p. 1, doi. 10.1093/dote/dox082
    By:
    • Butter, R.;
    • Lagarde, S. M.;
    • van Oijen, M. G. H.;
    • Anderegg, M. C. J.;
    • Gisbertz, S. S.;
    • Meijer, S. L.;
    • Hulshof, M. C. C. M.;
    • Bergman, J. J. G. H. M.;
    • van Berge Henegouwen, M. I.;
    • van Laarhoven, H. W. M.
    Publication type:
    Article
    20
    21
    22
    23
    24

    Preoperative image-guided identification of response to neoadjuvant chemoradiotherapy in esophageal cancer (PRIDE): a multicenter observational study.

    Published in:
    2018
    By:
    • Borggreve, A. S.;
    • Mook, S.;
    • Verheij, M.;
    • Mul, V. E. M.;
    • Bergman, J. J.;
    • Bartels-Rutten, A.;
    • Beek, L. C. ter;
    • Beets-Tan, R. G. H.;
    • Bennink, R. J.;
    • van Berge Henegouwen, M. I.;
    • Brosens, L. A. A.;
    • Defize, I. L.;
    • van Dieren, J. M.;
    • Dijkstra, H.;
    • van Hillegersberg, R.;
    • Hulshof, M. C.;
    • van Laarhoven, H. W. M.;
    • Lam, M. G. E. H.;
    • van Lier, A. L. H. M. W.;
    • Muijs, C. T.
    Publication type:
    journal article
    25

    Team dynamics and clinician's experience influence decisionmaking during Upper-GI multidisciplinary team meetings: A multiple case study.

    Published in:
    Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1003506
    By:
    • Luijten, J. C. H. B. M.;
    • Westerman, M. J.;
    • Nieuwenhuijzen, G. A. P.;
    • Walraven, J. E. W.;
    • Sosef, M. N.;
    • Beerepoot, L. V.;
    • van Hillegersberg, R.;
    • Muller, K.;
    • Hoekstra, R.;
    • Bergman, J. J. G. H. M.;
    • Siersema, P. D.;
    • van Laarhoven, H. W. M.;
    • Rosman, C.;
    • Brom, L.;
    • Vissers, P. A. J.;
    • Verhoeven, R. H. A.
    Publication type:
    Article
    26

    Focal adhesion kinase inhibition synergizes with nab-paclitaxel to target pancreatic ductal adenocarcinoma.

    Published in:
    Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-01892-z
    By:
    • Le Large, T. Y. S.;
    • Bijlsma, M. F.;
    • El Hassouni, B.;
    • Mantini, G.;
    • Lagerweij, T.;
    • Henneman, A. A.;
    • Funel, N.;
    • Kok, B.;
    • Pham, T. V.;
    • de Haas, R.;
    • Morelli, L.;
    • Knol, J. C.;
    • Piersma, S. R.;
    • Kazemier, G.;
    • van Laarhoven, H. W. M.;
    • Giovannetti, E.;
    • Jimenez, C. R.
    Publication type:
    Article
    27
    28

    Prognostic value of patient-reported quality of life for survival in oesophagogastric cancer: analysis from the population-based POCOP study.

    Published in:
    Gastric Cancer, 2021, v. 24, n. 6, p. 1203, doi. 10.1007/s10120-021-01209-1
    By:
    • van Kleef, J. J.;
    • Dijksterhuis, W. P. M.;
    • van den Boorn, H. G.;
    • Prins, M.;
    • Verhoeven, R. H. A.;
    • Gisbertz, S. S.;
    • Slingerland, M.;
    • Mohammad, N. Haj;
    • Creemers, G.-J.;
    • Neelis, K. J.;
    • Heisterkamp, J.;
    • Rosman, C.;
    • Ruurda, J. P.;
    • Kouwenhoven, E. A.;
    • van de Poll-Franse, L. V.;
    • van Oijen, M. G. H.;
    • Sprangers, M. A. G.;
    • van Laarhoven, H. W. M.
    Publication type:
    Article
    29
    30
    31
    32
    33

    Postoperative Complications and Long-Term Quality of Life After Multimodality Treatment for Esophageal Cancer: An Analysis of the Prospective Observational Cohort Study of Esophageal-Gastric Cancer Patients (POCOP).

    Published in:
    Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 12, p. 7259, doi. 10.1245/s10434-021-10144-5
    By:
    • Jezerskyte, E.;
    • van Berge Henegouwen, M. I.;
    • van Laarhoven, H. W. M.;
    • van Kleef, J. J.;
    • Eshuis, W. J.;
    • Heisterkamp, J.;
    • Hartgrink, H. H.;
    • Rosman, C.;
    • van Hillegersberg, R.;
    • Hulshof, M. C. C. M.;
    • Sprangers, M. A. G.;
    • Gisbertz, S. S.
    Publication type:
    Article
    34
    35

    Recurrent disease detection after resection of pancreatic ductal adenocarcinoma using a recurrence-focused surveillance strategy (RADAR-PANC): protocol of an international randomized controlled trial according to the Trials within Cohorts design.

    Published in:
    Trials, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s13063-024-08223-5
    By:
    • Daamen, L. A.;
    • van Goor, I. W. J. M.;
    • Groot, V. P.;
    • Andel, P. C. M.;
    • Brosens, L. A. A.;
    • Busch, O. R.;
    • Cirkel, G. A.;
    • Mohammad, N. Haj;
    • Heerkens, H. D.;
    • de Hingh, I. H. J. T.;
    • Hoogwater, F.;
    • van Laarhoven, H. W. M.;
    • Los, M.;
    • Meijer, G. J.;
    • de Meijer, V. E.;
    • Pande, R.;
    • Roberts, K. J.;
    • Stoker, J.;
    • Stommel, M. W. J.;
    • van Tienhoven, G.
    Publication type:
    Article
    36

    Recurrent disease detection after resection of pancreatic ductal adenocarcinoma using a recurrence-focused surveillance strategy (RADAR-PANC): protocol of an international randomized controlled trial according to the Trials within Cohorts design.

    Published in:
    Trials, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s13063-024-08223-5
    By:
    • Daamen, L. A.;
    • van Goor, I. W. J. M.;
    • Groot, V. P.;
    • Andel, P. C. M.;
    • Brosens, L. A. A.;
    • Busch, O. R.;
    • Cirkel, G. A.;
    • Mohammad, N. Haj;
    • Heerkens, H. D.;
    • de Hingh, I. H. J. T.;
    • Hoogwater, F.;
    • van Laarhoven, H. W. M.;
    • Los, M.;
    • Meijer, G. J.;
    • de Meijer, V. E.;
    • Pande, R.;
    • Roberts, K. J.;
    • Stoker, J.;
    • Stommel, M. W. J.;
    • van Tienhoven, G.
    Publication type:
    Article
    37
    38

    Correction: A nationwide randomized controlled trial on additional treatment for isolated local pancreatic cancer recurrence using stereotactic body radiation therapy (ARCADE).

    Published in:
    2023
    By:
    • van Goor, I. W. J. M.;
    • Daamen, L. A.;
    • Besselink, M. G.;
    • Bruynzeel, A. M. E.;
    • Busch, O. R.;
    • Cirkel, G. A.;
    • Koerkamp, B. Groot;
    • Mohammed, N. Haj;
    • Heerkens, H. D.;
    • van Laarhoven, H. W. M.;
    • Meijer, G. J.;
    • Nuyttens, J.;
    • van Santvoort, H. C.;
    • van Tienhoven, G.;
    • Verkooijen, H. M.;
    • Wilmink, J. W.;
    • Molenaar, I. Q.;
    • Intven, M. P. W.
    Publication type:
    Correction Notice
    39

    A nationwide randomized controlled trial on additional treatment for isolated local pancreatic cancer recurrence using stereotactic body radiation therapy (ARCADE).

    Published in:
    2022
    By:
    • van Goor, I. W. J. M.;
    • Daamen, L. A.;
    • Besselink, M. G.;
    • Bruynzeel, A. M. E.;
    • Busch, O. R.;
    • Cirkel, G. A.;
    • Groot Koerkamp, B.;
    • Haj Mohammed, N.;
    • Heerkens, H. D.;
    • van Laarhoven, H. W. M.;
    • Meijer, G. J.;
    • Nuyttens, J.;
    • van Santvoort, H. C.;
    • van Tienhoven, G.;
    • Verkooijen, H. M.;
    • Wilmink, J. W.;
    • Molenaar, I. Q.;
    • Intven, M. P. W.;
    • Dutch Pancreatic Cancer Group
    Publication type:
    journal article
    40

    Supervised exercise after oesophageal cancer surgery: the PERFECT multicentre randomized clinical trial.

    Published in:
    British Journal of Surgery, 2021, v. 108, n. 7, p. 786, doi. 10.1093/bjs/znab078
    By:
    • van Vulpen, J. K.;
    • Hiensch, A. E.;
    • van Hillegersberg, R.;
    • Ruurda, J. P.;
    • Backx, F. J. G.;
    • Nieuwenhuijzen, G. A. P.;
    • Kouwenhoven, E. A.;
    • Groenendijk, R. P. R.;
    • van der Peet, D. L.;
    • Hazebroek, E. J.;
    • Rosman, C.;
    • Wijnhoven, B. P. L.;
    • van Berge Henegouwen, M. I.;
    • van Laarhoven, H. W. M.;
    • Siersema, P. D.;
    • May, A. M.
    Publication type:
    Article
    41
    42

    FOXO transcriptional activity is associated with response to chemoradiation in EAC.

    Published in:
    2022
    By:
    • Creemers, A.;
    • van der Zalm, A. P.;
    • van de Stolpe, A.;
    • Holtzer, L.;
    • Stoffels, M.;
    • Hooijer, G. K. J.;
    • Ebbing, E. A.;
    • van Ooijen, H.;
    • van Brussel, A. G. C.;
    • Aussems-Custers, E. M. G.;
    • van Berge Henegouwen, M. I.;
    • Hulshof, M. C. C. M.;
    • Bergman, J. J. G. H. M.;
    • Meijer, S. L.;
    • Bijlsma, M. F.;
    • van Laarhoven, H. W. M.
    Publication type:
    journal article